Humanization of a murine monoclonal antibody by simultaneous optimisation of framework and CDR residues

被引:37
作者
Wu, HR [1 ]
Nie, Y [1 ]
Huse, WD [1 ]
Watkins, JD [1 ]
机构
[1] Ixsys Inc, San Diego, CA 92121 USA
关键词
antibody engineering; capture lift; codon-based mutagenesis; combinatorial antibody libraries;
D O I
10.1006/jmbi.1999.3141
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Optimal protein function often depends on co-operative interactions between amino acid residues distant in the protein primary sequence yet spatially near one another following protein folding. For example, antibody affinity is influenced by interactions of framework residues with complementarity-determining region (CDR) residues. However, despite the abundance of antibody structural information and computational tools the humanization of rodent antibodies for clinical use often results in a significant loss of affinity. To date, antibody engineering efforts have focused either on optimizing CDR residues involved in antigen binding or on optimizing antibody framework residues that serve critical roles in preserving the conformation of CDRs. In the present study a new approach which permits the rapid identification of co-operatively interacting framework and CDR residues was used to simultaneously humanize and optimize a murine antibody directed against CD40. Specifically, a combinatorial library that examined eight potentially important framework positions concomitantly with focused CDR libraries consisting of variants containing random single amino acid mutations in the third CDR of the heavy and light chains was expressed. Multiple anti-CD40 Fab variants containing as few as one murine framework residue and displaying up to approximate to 500-fold higher affinity than the initial chimeric Fab were identified. The higher affinity humanized variants demonstrated a cooperative interaction between light chain framework residue Y49 and heavy chain CDR3 residue R/K101 (coupling energy, Delta G(I) = 0.9 kcal/mol). Screening of combinatorial framework-CDR libraries permits identification of monoclonal antibodies (mAb) with structures optimized for function, including instances in which the antigen induces conformational changes in the mAb. Moreover, the enhanced humanized variants contain fewer murine framework residues and could not be identified by sequential in vitro humanization and affinity muturation strategies. This approach to identifying co-operatively interacting residues is not restricted to antibody-antigen interactions and consequently, may be used broadly to gain insight into protein structure-function relationships, including proteins that serve as catalysts. (C) 1999 Academic Press.
引用
收藏
页码:151 / 162
页数:12
相关论文
共 45 条
[21]  
KRISTENSSON K, 1995, VACCINES, P39
[23]   Reduction of atherosclerosis in mice by inhibition of CD40 signalling [J].
Mach, F ;
Schönbeck, U ;
Sukhova, GK ;
Atkinson, E ;
Libby, P .
NATURE, 1998, 394 (6689) :200-203
[24]  
MARKS JD, 1992, J BIOL CHEM, V267, P16007
[25]   PHAGE ANTIBODIES - FILAMENTOUS PHAGE DISPLAYING ANTIBODY VARIABLE DOMAINS [J].
MCCAFFERTY, J ;
GRIFFITHS, AD ;
WINTER, G ;
CHISWELL, DJ .
NATURE, 1990, 348 (6301) :552-554
[26]  
MILLER RA, 1983, BLOOD, V62, P988
[27]   CHIMERIC HUMAN-ANTIBODY MOLECULES - MOUSE ANTIGEN-BINDING DOMAINS WITH HUMAN CONSTANT REGION DOMAINS [J].
MORRISON, SL ;
JOHNSON, MJ ;
HERZENBERG, LA ;
OI, VT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (21) :6851-6855
[28]   A HAPTEN-SPECIFIC CHIMAERIC IGE ANTIBODY WITH HUMAN PHYSIOLOGICAL EFFECTOR FUNCTION [J].
NEUBERGER, MS ;
WILLIAMS, GT ;
MITCHELL, EB ;
JOUHAL, SS ;
FLANAGAN, JG ;
RABBITTS, TH .
NATURE, 1985, 314 (6008) :268-270
[29]   A POSSIBLE PROCEDURE FOR REDUCING THE IMMUNOGENICITY OF ANTIBODY VARIABLE DOMAINS WHILE PRESERVING THEIR LIGAND-BINDING PROPERTIES [J].
PADLAN, EA .
MOLECULAR IMMUNOLOGY, 1991, 28 (4-5) :489-498
[30]   ANATOMY OF THE ANTIBODY MOLECULE [J].
PADLAN, EA .
MOLECULAR IMMUNOLOGY, 1994, 31 (03) :169-217